US2021106035A1PendingUtilityA1
Nutritional composition
Est. expiryJun 8, 2038(~11.9 yrs left)· nominal 20-yr term from priority
A61K 36/48A61K 31/6615A23L 33/40A23L 33/21A23L 33/165A23L 33/16A23L 11/05A23L 7/197A23L 7/115A23L 7/101A23L 7/10A23V 2002/00A23L 11/01A23L 33/105
59
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
Use of a lentil product to increase the bioavailability of non-haem iron in a composition comprising one or more anti-nutritional factors.
Claims
exact text as granted — not AI-modified1 . A method to increase the bioavailability of non-haem iron in a composition comprising one or more anti-nutritional factor, the method comprising adding a lentil product to the composition.
2 . The method according to claim 1 wherein the lentil product is selected from the group consisting of a yellow lentil product, a red lentil product, and a combination of the foregoing.
3 . The method according to claim 1 wherein the one or more anti-nutritional factor is phytic acid.
4 . The method according to claim 1 wherein the composition comprising one or more anti-nutritional factor comprises wholegrain.
5 . The method according to claim 4 wherein the wholegrain is selected from the group consisting of whole grain maize, wheat, rice, oat, corn, barley, rye, semolina, and a combination of any of the foregoing.
6 . The method according to claim 1 wherein the non-haem iron is selected from the group consisting of ferrous sulfate, ferrous bisglycinate, ferrous fumarate and a combination thereof.
7 . A composition comprising a lentil product, non-haem iron and wholegrain, wherein the composition is an infant cereal or a nutritional composition for use in a complementary feeding period.
8 . The composition according to claim 7 wherein the lentil product is selected from the group consisting of a yellow lentil product, a red lentil product, and a combination of the foregoing.
9 . The composition according to claim 7 , wherein said composition comprises 5 to 70% of the lentil product.
10 . The composition according to claim 7 wherein said composition comprises 5 to 30% of the wholegrain.
11 . The composition according to claim 7 wherein said composition comprises 5 to 30% of the wholegrain, at least 1.6 mg/100 kcal of the non-haem iron, and 5 to 20% of the lentil product.
12 . The composition according to claim 7 wherein the wholegrain is selected from the group consisting of wholegrain maize, wheat, rice, oat, corn, barley, rye, semolina and a combination of any of the foregoing.
13 . A method for treatment or prevention of sub-optimal iron levels in an infant or child, the method comprising administering an effective amount of a composition comprising a lentil product, non-haem iron and wholegrain to the infant or child.
14 . A method to maintain or optimize the iron status of an infant or child, the method comprising administering an effective amount of a composition comprising a lentil product, non-haem iron and wholegrain to the infant or child.
15 . (canceled)Join the waitlist — get patent alerts
Track US2021106035A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.